342.46MMarket Cap3.25P/E (TTM)
7.170High6.490Low197.45KVolume6.640Open6.620Pre Close1.37MTurnover2.69%Turnover RatioLossP/E (Static)47.90MShares14.50052wk High4.07P/B52.43MFloat Cap5.75052wk Low--Dividend TTM7.33MShs Float14.500Historical High--Div YieldTTM10.27%Amplitude5.750Historical Low6.925Avg Price1Lot Size
Fractyl Health Stock Forum
In a groundbreaking development for the field of obesity management, Fractyl Health has received FDA Investigational Device Exemption (IDE) approval for its pivotal Revita® Remain-1 study. This marks a significant milestone in providing durable weight maintenance solutions for patients after the discontinuation of GLP-1 based drugs. With ...
Globe Newswire 1-Apr-2024 6:00 AM
No comment yet